Page last updated: 2024-09-05

phosphatidylcholines and Splenic Diseases

phosphatidylcholines has been researched along with Splenic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chanock, SJ; Figg, WD; Gupta, R; Hill, S; Jarosinski, P; Piscitelli, S; Pizzo, PA; Walsh, TJ; Whitcomb, P1
Philips, DL; Sallah, S; Sallah, W; Semelka, RC; Vainright, JR1

Trials

1 trial(s) available for phosphatidylcholines and Splenic Diseases

ArticleYear
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9

    Topics: Adolescent; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Drug Combinations; Female; Humans; Liver Diseases; Male; Phosphatidylcholines; Phosphatidylglycerols; Splenic Diseases

1997

Other Studies

1 other study(ies) available for phosphatidylcholines and Splenic Diseases

ArticleYear
Amphotericin B lipid complex for the treatment of patients with acute leukemia and hepatosplenic candidiasis.
    Leukemia research, 1999, Volume: 23, Issue:11

    Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Candidiasis; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Leukemia, Myeloid; Liver Diseases; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Splenic Diseases

1999